A probe for early screening of oral cancer based on saliva, a non-invasive visualization kit and its use and method of use
By regulating the amount of VEGF165 protein in saliva using the VEGF165-G4probe probe and utilizing the catalytic activity of G4zyme, a non-invasive, simple, and highly sensitive screening method for oral squamous cell carcinoma can be achieved. This method solves the problems of high invasiveness, high false positive rate, complex operation, and high cost in existing technologies, and provides a screening method with high specificity and high sensitivity.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SICHUAN UNIV
- Filing Date
- 2026-01-28
- Publication Date
- 2026-05-29
AI Technical Summary
Existing technologies are insufficient for non-invasive, simple, and highly sensitive screening and auxiliary diagnosis of oral squamous cell carcinoma, especially due to the problems of traditional methods being highly invasive, having a high false positive rate, being complex to operate, or being costly.
The VEGF165-G4probe probe was used to form G4zyme by binding the VEGF165 aptamer to Hemin. The catalytic activity of G4zyme was regulated by the change in the amount of VEGF165 protein in saliva, so as to achieve visual detection. A VEGF165-G4probe kit was constructed for oral cancer screening.
It achieves highly specific and sensitive screening for oral squamous cell carcinoma, simplifies the operation process, reduces the false positive rate, and lowers costs.
Smart Images

Figure CN122104713A_ABST